Cisplatin-associated neuropathy characteristics compared to those associated with other neurotoxic chemotherapy agents (Alliance A151724) Albany, Costantine , Dockter, Travis , Wolfe, Eric ... - - Support Care Cancer - 2021 Manuscript - Primary - Primary - Symptom Inter - A151724
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993) Atherton, Pamela J. , Burger, Kelli N. , Loprinzi, Charles L. ... - - Support Care Cancer - 2012 Manuscript - Primary - Primary - Symptom Inter - N0993
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 Barton, Debra L. , Burger, Kelli , Novotny, Paul J. , Fitch, Tom R. ... - - Support Care Cancer - 2013 Manuscript - Primary - Primary - Symptom Inter - N00C9
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance) Barton, Debra L. , Shuster, Lynne T. , Dockter, Travis ... - - Support Care Cancer - 2018 Manuscript - Secondary - Primary - Symptom Inter - N10C1
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance) Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T. , Gill, Paula ... - - Support Care Cancer - 2018 Manuscript - Primary - Primary - Symptom Inter - N10C1
Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance) Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T , Gill, Paula ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Symptom Inter - N10C1
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA Barton, Debra L. , Soori, Gamini S. , Bauer, Brent A. ... - - Support Care Cancer - 2010 Manuscript - Primary - Primary - Symptom Inter - N03CA
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance) Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. ... - - Cancer - 2014 Manuscript - Primary - Primary - Symptom Inter - N08C3
A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance) Barton, Debra L , Atherton, Pamela J , Satele, Daniel V , Qin, Rui ... - - Support Care Cancer - 2020 Manuscript - Primary - Primary - Symptom Inter - NCCTG-N07C4
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J. Natl. Cancer Inst. - 2007 Manuscript - Primary - Primary - Symptom Inter - NCCTG-N02C3
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014 Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08C1 , N08CA
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) Boora, Ganesh K. , Kanwar, Rahul , Kulkarni, Amit A. , Abyzov, Alexej ... - - Cancer Med - 2016 Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance) Boora, Ganesh K. , Kulkarni, Amit A. , Kanwar, Rahul ... - - J. Neurol. Sci. - 2015 Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08CA
A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102 Cathcart-Rake, Elizabeth , Novotny, Paul , Leon-Ferre, Roberto ... - - Support Care Cancer - 2021 Manuscript - Primary - Primary - Symptom Inter - A221102
Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB) Cheville, Andrea L. , Sloan, Jeff A. , Northfelt, Donald W. ... - - Support Care Cancer - 2009 Manuscript - Primary - Primary - Symptom Inter - N01CB
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Croghan, Ivana T , Hurt, Richard D , Dakhil, Shaker R ... - - Mayo Clin. Proc. - 2007 Manuscript - Primary - Primary - Prevention - NCCTG-N99C4
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7 Grothey, Axel , Nikcevich, Daniel A. , Sloan, Jeff A. ... - - J Clin Oncol - 2011 Manuscript - Primary - Primary - Symptom Inter - N04C7
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases Himelstein, Andrew L. , Foster, Jared C. , Khatcheressian, James L. ... - - JAMA - 2017 Manuscript - Primary - Primary - Symptom Inter - CALGB-79804 , CALGB-70604 , CALGB-150804
CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer Himelstein, Andrew L. , Qin, Rui , Novotny, Paul J. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Symptom Inter - CALGB-70604
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC Hines, Stephanie L. , Mincey, Betty , Dentchev, Todor ... - - Breast Cancer Res. Treat. - 2009 Manuscript - Primary - Primary - Symptom Inter - N03CC
Prophylactic Tetracycline Does Not Diminish the Severity of Epidermal Growth Factor Receptor (EGFR) Inhibitor Induced Rash: Results from the North Central Cancer Treatment Group (Supplementary N03CB)1 Jatoi, Aminah , Dakhil, Shaker R. , Sloan, Jeff A. , Kugler, John W. ... - - Support Care Cancer - 2011 Manuscript - Secondary - Primary - Symptom Inter - N03CB
A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites (N04C2) Jatoi, Aminah , Nieva, Jorge J. , Qin, Rui , Loprinzi, Charles L. ... - - Oncology - 2012 Manuscript - Primary - Primary - Symptom Inter - N04C2
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Jatoi, Aminah , Ritter, Howard L , Dueck, Amylou , Nguyen, Phuong L ... - - Lung Cancer - 2010 Manuscript - Primary - Primary - Symptom Inter - N01C9
Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-Induced Skin Rashes: Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N03CB)1 Jatoi, Aminah , Rowland, Kendrith , Sloan, Jeff A. , Gross, Howard M. ... - - Cancer - 2008 Manuscript - Primary - Primary - Symptom Inter - N03CB
Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4) Jatoi, Aminah , Thrower, Abby , Sloan, Jeff A. , Flynn, Patrick J. ... - - Oncologist - 2010 Manuscript - Primary - Primary - Prevention - N05C4
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8 Kearns, Ann E. , Northfelt, Donald W. , Dueck, Amylou C. ... - - Support Care Cancer - 2010 Manuscript - Primary - Primary - Symptom Inter - N01C8
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial Kottschade, Lisa A. , Sloan, Jeff A. , Mazurczak, Miroslaw A. ... - - Support Care Cancer - 2011 Manuscript - Primary - Primary - Symptom Inter - N05C3
RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial N08C1 Kulkarni, Amit A. , Boora, Ganesh , Kanwar, Rahul , Ruddy, Kathryn J. ... - - Acta Oncol - 2015 Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1
Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017 Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08CA , N08CB
NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study Leal, Alexis D. , Qin, Rui , Atherton, Pamela J. , Haluska, Paul ... - - Cancer - 2014 Manuscript - Primary - Primary - Symptom Inter - N08CA
Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance]) Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - Symptom Inter - N09C6
A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance study A221102 Leon-Ferre, Roberto A. , Novotny, Paul , Terstriep, Shelby ... - SABCS - Cancer Res - 2019 Abstract - Primary - Primary - Symptom Inter - A221102
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1 Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010 Manuscript - Primary - Primary - Symptom Inter - N07C1
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014 Manuscript - Primary - Primary - Symptom Inter - N08CB
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. Loprinzi, Charles L , Kugler, John W , Barton, Debra L ... - - J. Clin. Oncol. - 2007 Manuscript - Primary - Primary - Symptom Inter - N03C5
A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus “Magic Mouthwash” versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304) Miller, Robert C. , Le-Rademacher, Jennifer , Sio, Terence ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Abstract - Primary - Primary - Symptom Inter - A221304
N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine vs Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy Miller, Robert C. , Petereit, Daniel G. , Sloan, Jeff A. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Manuscript - Primary - Primary - Symptom Inter - N08C9
Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase 3 Double-Blind, Randomized Trial from the North Central Cancer Treatment Group N06C4 Miller, Robert C. , Schwartz, David J. , Sloan, Jeff A. ... - - Int J Radiat Oncol Biol Phys - 2011 Manuscript - Primary - Primary - Symptom Inter - N06C4
Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting Navari, Rudolph M. , Pywell, Cameron M. , Le-Rademacher, Jennifer G. ... - - JAMA Oncol - 2020 Manuscript - Primary - Primary - Symptom Inter - Pilot , NCT03137121
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - - N. Engl. J. Med. - 2016 Manuscript - Primary - Primary - Symptom Inter - A221301
Olanzapine For The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Patients Receiving Highly Emetogenic Chemotherapy (HEC): Alliance A221301 A Randomized, Double-Blind, Placebo-Controlled Trial Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - ASCO Pal - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Symptom Inter - A221301
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4) Neben-Wittich, Michelle A. , Atherton, Pamela J. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2011 Manuscript - Secondary - Primary - Symptom Inter - N06C4
Randomized Clinical Trial of Imiquimod: An Adjunct to Treating Cervical Dysplasia Pachman, Deirdre R. , Barton, Debra L. , Clayton, Amy H. ... - - Am J Obstet Gynecol - 2012 Manuscript - Primary - Primary - Prevention - NCCTG-989251
Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary - Primary - Symptom Inter - N08CB
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Symptom Inter - N08CB
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew ... - - Support Care Cancer - 2016 Manuscript - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB
NCCTG N10C2 (Alliance) – A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - - Menopause - 2015 Manuscript - Primary - Primary - Symptom Inter - N10C2
NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Symptom Inter - N10C2
A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes1:NCCTG N08C7 Pruthi, Sandhya , Qin, Rui , Terstreip, Shelby A. , Liu, Heshan ... - - Menopause - 2012 Manuscript - Primary - Primary - Symptom Inter - N08C7
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Reeves, Brandi N , Dakhil, Shaker R , Sloan, Jeff A , Wolf, Sherry L ... - - Cancer - 2012 Manuscript - Secondary - Long-Term-Followup - Symptom Inter - N08C1
A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance) Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. Sandler, Robert S , Halabi, Susan , Baron, John A , Budinger, Susan ... - - N. Engl. J. Med. - 2003 Manuscript - Primary - Primary - GI - CALGB-9270
Repeated Measures Analyses of Dermatitis Symptom Evolution in Breast Cancer Patients Receiving Radiotherapy in a Phase 3 Randomized Trial of Mometasone Furoate vs Placebo (N06C4 [Alliance]) Sio, Terence T. , Atherton, Pamela J. , Birckhead, Brandon J ... - - Support Care Cancer - 2016 Manuscript - Secondary - Primary - Symptom Inter - N06C4
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain Sio, Terence T. , Le-Rademacher, Jennifer G. , Leenstra, James L. ... - - JAMA - 2019 Manuscript - Primary - Primary - Symptom Inter - A221304
A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance) Thanarajasingam, Gita , Atherton, Pamela J. , Novotny, Paul J. ... - - Lancet Oncol. - 2016 Manuscript - Secondary-not-in-original - Primary - Health Outcome - N9741 , NCCTG-97-92-54
5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen: N03CC (Alliance) Wagner-Johnston, Nina D. , Sloan, Jeff A. , Liu, Heshan ... - - Cancer - 2015 Manuscript - Primary - Long-Term-Followup - Symptom Inter - N03CC
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010 Manuscript - Primary - Primary - Symptom Inter - N05C5
Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial. Zimmerman, Collin Thomas , Atherton, Pamela J. , Pachman, Deirdre R. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Symptom Inter - NCT01611155
Venlafaxine to Prevent Oxaliplatin-Induced Neuropathy? A Pilot Randomized Placebo Controlled Trial Zimmerman, Collin , Atherton, Pam , Pachman, Deirdre , Seisler, Drew ... - MASCC / ISOO - Support Care Cancer - 2015 Abstract - Primary - Primary - Symptom Inter - NCT01611155
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy Zimmerman, Collin , Atherton, Pamela J. , Pachman, Deirdre ... - - Support Care Cancer - 2016 Manuscript - Primary - Primary - Symptom Inter - NCT01611155
